Short-Term Debt to Equity Ratio: Synaptogenix, Inc. (SNPX)
Synaptogenix, Inc. (SNPX) possesses the potential for full pricing power thanks to bryostatin-1, which restores neural connections in dementia. The price trend with the 0.00 indicator complements data regarding collaborations with clinics for testing cognitive drugs. The business currently relies on a single molecule, remaining in the preparation stage for new trial phases following a structural reorganization.
Analytical breakdowns and data insights for company synaptogen.com (SNPX)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Debt to Equity Synaptogenix, Inc.|SNPX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Synaptogenix|SNPX - Company Cumulative Debt|Debt to Book Capitalization Ratio Synaptogenix Inc.|SNPX - Company Long-Term Indebtedness|Company Short-Term Debts Synaptogenix|Quick Liquidity synaptogen.com
- company profitability and valuation multiples indicators:
Analysis of all company metrics:SNPX Neurotrope
For the small scientific team at Synaptogenix, Inc. (SNPX), the change in the ratio of short loans to equity on the GURU.Markets platform serves as an indicator of financial stability, where the daily division of short-term liabilities by equity allows for the tracking of share dilution risks and an assessment of the effectiveness of resource austerity measures amid limited market confidence in early-stage neuro-drugs.
Who Synaptogenix, Inc. competes with
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Short-Term Debt to Equity|Current Liabilities to Capital Supernus Corp (SUPN)|Short-Term Debt to Equity Catalyst Pharmaceuticals|denalitherapeutics.com (DNLI) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio HRMY (Harmony Biosciences Holdings, Inc.)|BHVN - Current Liabilities to Capital|Short-Term Debt to Equity Amylyx AMLX|TRVI: Short-Term Debt to Capital Ratio|Praxis Precision Medicines - Short-Term Debt to Capital|AVXL - Short-Term Debt to Capital|CeriBell (CBLL) - Short-Term Debt to Equity|Current Liabilities to Equity PRTA (Prothena Biosciences)|Short-Term Debt to Equity Ratio ALEC|ANNX (Annexon Biosciences Inc.) - Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Omeros Corporation (OMER)|NGNE - Current Liabilities to Capital|Short-Term Debt to Capital ACIU (AC Immune SA)|Short-Term Indebtedness to Equity Voyager Therapeutics Inc|Neumora Therapeutics Inc - Short-Term Debt to Capital|Current Liabilities to Capital Scilex Holding Company, Inc.|Tevogen Bio Holdings (TVGN) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ACOG|CGTX (Cognition Therapeutics, Inc.) - Short-Term Debt to Capital|Inhibikase Therapeutics Inc (IKT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio SAVA (Cassava)|assertiotx.com - Short-Term Debt to Capital Ratio|Coya Therapeutics - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital VTGN|Ovid Rx - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Acumen Pharmaceuticals Inc. ABOS|CervoMed Inc (CRVO) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ATHE|CLNN (Clene Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PepGen Corp (PEPG)|Short-Term Debt to Equity Ratio JUNS (Jupiter Neurosciences)|Short-Term Debt to Capital Coefficient Relmada Therapeutics Inc|Short-Term Debt to Equity Annovis Bio Corp ANVS|Short-Term Debt to Capital Coefficient Grace Therapeutics Inc (GRCE)|AIFF - Short-Term Debt to Equity|KLTO (Klotho Neurosciences Inc) - Short-Term Debt to Capital Ratio|neurosense-tx.com (NRSN) - Short-Term Debt to Equity|Current Liabilities to Equity RVPH (Reviva Pharmaceuticals Holdings Inc.)|Short-Term Debt to Equity Ratio MTVA|Short-Term Debt to Capital Ratio NRXS (NeurAxis Inc)|Short-Term Debt to Equity Helius Medical (HSDT)|passagebio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital NEUP (Neuphoria Therapeutics)|Minerva Neurosciences Inc (NERV) - Current Liabilities to Capital|ATHA: Short-Term Debt to Equity Ratio|ADXN - Short-Term Debt to Capital|alzamend.com (ALZN) - Short-Term Debt to Equity|Cyclerion Therapeutics, Inc. - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Protagenic Therapeutics Inc.|Current Liabilities to Capital Pasithea KTTA|Short-Term Debt to Equity Cortigent, Inc. (CRGT)|Short-Term Debt to Capital Coefficient Avenue Therapeutics Inc|Brainstorm Cell - Short-Term Debt to Equity Ratio|caratherapeutics.com (CARA) - Current Liabilities to Capital|CHRO - Short-Term Debt to Equity|ELYM (Eliem Therapeutics) - Short-Term Debt to Capital Ratio|ITCI: Short-Term Debt to Capital|Longboard (LBPH) - Short-Term Debt to Capital|Short-Term Debt to Equity Marinus Pharmaceuticals|nkgenbiotech.com - Current Liabilities to Equity|Short-Term Debt to Equity Ratio NRBO (NeuroBo Pharmaceuticals, Inc.)|Short-Term Loans to Capital Ratio SAGE|Short-Term Debt to Equity Trevena, Inc TRVN|Vigil Neuroscience Inc. (VIGL) - Current Liabilities to Capital|Anew Medical, Inc. - Short-Term Debt to Capital|Short-Term Indebtedness to Equity cerevel.com (CERE)